Global Continuous Glucose Monitoring Systems Market Size By Product Type (Sensors, Transmitters), By Application (Type 1 Diabetes, Type 2 Diabetes), By End-User (Home Healthcare, Hospitals), By Geographic Scope And Forecast

Continuous Glucose Monitoring Market Size And Forecast

Continuous Glucose Monitoring Market size was valued at USD 4.58 Billion in 2024 and is projected to reach USD 12.1 Billion by 2031, growing at a CAGR of 12.90% from 2024 to 2031.

• Continuous Glucose Monitoring (CGM) systems are medical devices that allow diabetics to monitor their glucose levels in real time. These devices include a tiny sensor implanted beneath the skin that detects glucose levels in interstitial fluid. The data is relayed to a display device, allowing users to continuously monitor their glucose levels during the day and night. CGMs assist patients in better controlling their diabetes by offering insights into glucose trends, allowing for prompt actions to prevent hyperglycemia and hypoglycemia. They are commonly used to manage both Type 1 and Type 2 diabetes, and they are especially advantageous to insulin-treated diabetics.
• CGM systems appear promising, owing to technological developments and increased knowledge of diabetes treatment. CGMs are increasingly being integrated with smartphone applications and insulin delivery devices to provide consumers with a more seamless experience. The development of non-invasive glucose monitoring devices, as well as more advanced data analysis algorithms, is projected to improve CGM accuracy and dependability. As healthcare moves toward personalized medicine, CGMs are anticipated to play an important role in adapting diabetes management programs to individual needs, ultimately improving patient outcomes and quality of life.

To Learn More: Download Report PDF

Global Continuous Glucose Monitoring Market Dynamics

The key market dynamics that are shaping the global continuous glucose monitoring market include:

Key Market Drivers:

• Rising Prevalence of Diabetes: The increasing prevalence of diabetes is a significant driver for the Continuous Glucose Monitoring (CGM) market, with the International Diabetes Federation (IDF), estimating a 46% increase in the number of individuals with diabetes from 537 million in 2021 to 783 million by 2045. This rise drives demand for effective diabetes management options, as CGM systems allow patients to continuously monitor their glucose levels and change their treatment plans as needed.
• Growing Adoption of Wearable Technology: The growing adoption of wearable technologies is propelling the market for Continuous Glucose Monitoring (CGM) systems. A study published in the Journal of Diabetes Science and Technology found that CGM use among persons with type 1 diabetes in the United States increased from 6% in 2011 to 38% in 2018, representing a more than six-fold rise in just seven years. This trend is being driven by the convenience and accessibility of CGM systems, which seamlessly link with smartphones and wearable devices, allowing users to rapidly monitor their glucose levels and receive real-time alerts.
• Increasing Focus on Preventive Healthcare: The increasing focus on preventative healthcare is driving up the demand for Continuous Glucose Monitoring (CGM) devices. According to the Centers for Disease Control and Prevention (CDC), 96 million American adults, or more than one in every three, have prediabetes, indicating a significant potential market for CGM systems as preventive interventions. There is a rising recognition of the necessity of early intervention in blood glucose management to prevent diabetes progression.

Key Challenges:

• Integration with Existing Health Systems: To provide successful diabetic care, CGM data must be effortlessly integrated with electronic health records (EHR) and other health management systems. However, many healthcare systems lack the infrastructure to efficiently integrate CGM data. This problem can impede healthcare practitioners’ capacity to effectively monitor patients and convey critical findings, limiting the potential benefits of CGM devices and influencing their acceptance in clinical settings.
• User Training and Compliance: To use CGM systems successfully, users must receive sufficient training and maintain ongoing compliance. Patients must grasp how to use the devices effectively, evaluate the data, and incorporate the results into their normal diabetes management routines. Inadequate training can lead to errors in utilization and a lack of confidence in the device, resulting in lower adherence and, ultimately, limiting the benefits of CGM systems.
• Regulatory Challenges: CGM producers may find it difficult and time-consuming to navigate the regulatory landscape for medical devices. Delays in acquiring permits and complying with severe safety requirements might impede the introduction of new and innovative CGM technologies to the market. These regulatory obstacles might delay industry expansion and limit the availability of innovative diabetes therapies.

Key Trends:

• Focus on Personalized Healthcare: Patients are seeking specialized solutions to effectively manage their diabetes, which is driving the CGM market. CGM devices enable tailored monitoring and data analysis, allowing patients to make informed decisions based on their specific glucose patterns. The trend toward personalized treatment programs is boosting demand for CGM equipment, which provides a more tailored approach to diabetes care.
• Integration with Digital Health Solutions: Integrating CGM systems with digital health platforms, like as telemedicine and mobile health applications, improves their usability and appeal. These connections enable real-time data sharing with healthcare practitioners, resulting in improved communication and rapid actions. As telemedicine becomes increasingly common, the ability to connect CGM data to digital health solutions drives market growth by boosting patient engagement and care management.
• Collaboration with Technology Companies: Collaborations between CGM manufacturers and technology firms promote innovation and improve product offerings. CGM providers can improve user experience by collaborating with digital companies to use cutting-edge technology like mobile apps and cloud-based data analysis. These collaborations are boosting market growth by developing enhanced CGM solutions that are more accessible and user-friendly for both patients and healthcare professionals.

What's inside a VMR
industry report?

Our reports include actionable data and forward-looking analysis that help you craft pitches, create business plans, build presentations and write proposals.

>>> Ask For Discount @ – https://www.verifiedmarketresearch.com/ask-for-discount/?rid=39096

Global Continuous Glucose Monitoring Market Regional Analysis

Here is a more detailed regional analysis of the global continuous glucose monitoring market:

North America:

• North America continues to lead the continuous glucose monitoring (CGM) market, owing to the high prevalence of diabetes, advanced healthcare infrastructure, and the dominance of key CGM manufacturers. As of 2022, roughly 37.3 million Americans (11.3% of the population) have diabetes, with another 96 million adults classed as prediabetic, indicating a high demand for CGM devices. The adoption of CGM technology has increased significantly, with utilization among persons with type 1 diabetes in the United States increasing from 6% in 2011 to 38% in 2018. The American Diabetes Association’s 2023 guidelines advocate CGM for all persons receiving multiple daily injections or insulin pump therapy, emphasizing its usefulness in diabetes management.
• The favorable reimbursement regulations in the US have considerably assisted the adoption of CGM technology, particularly after the Centers for Medicare & Medicaid Services (CMS) approved coverage for certain CGM devices in 2017, increasing access for millions of older persons. Looking ahead, the North American CGM market is expected to increase steadily, led by continued FDA approvals of novel systems, including the first fully implanted CGM device in 2018. According to industry research, the global CGM market is expected to reach USD 10.4 Billion by 2027, with North America continuing to dominate. The growing emphasis on customized care, as well as the integration of CGM data with artificial intelligence and machine learning, are projected to drive future innovation and market progress in the region.

Asia Pacific:

• The Asia-Pacific region is rapidly emerging as the fastest-growing market for Continuous Glucose Monitoring (CGM) systems, owing to a combination of factors such as rising diabetes prevalence, rising disposable incomes, and increased healthcare costs. Countries such as China, India, and Japan are driving this increase as diabetes awareness grows and demand for modern healthcare solutions rises. According to the International Diabetes Federation’s (IDF) Diabetes Atlas 2021, the Western Pacific region has 206 million adults with diabetes in 2021, with forecasts of 260 million by 2045, emphasizing the vital need for appropriate monitoring technologies.
• The Asia-Pacific region’s rapid adoption of CGM technology reflects this essential need, with research indicating a considerable increase in utilization among persons with type 1 diabetes in Japan—from 5% in 2014 to 56% in 2020. Nations such as China and India are making significant investments in healthcare infrastructure and diabetes control programs, creating a favorable climate for CGM makers. As knowledge of the benefits of continuous glucose monitoring grows and healthcare systems improve, demand for CGM devices is likely to rise, maintaining Asia-Pacific’s position as the world’s fastest-growing market for these systems.

Global Continuous Glucose Monitoring Market: Segmentation Analysis

The Global Continuous Glucose Monitoring Market is Segmented on the basis of Product Type, Application, End-User, And Geography.

Continuous Glucose Monitoring Market, By Product Type

• Sensors
• Transmitters
• Integrated Insulin Pumps

Based on Product Type, the market is fragmented into Sensors, Transmitters, and Integrated Insulin Pumps. Sensors are currently the leading segment as they provide real-time glucose monitoring and play an important role in patient management. Sensor technology developments, such as enhanced accuracy and wearability, have contributed significantly to their market dominance. The integrated insulin pump segment is the fastest-growing category, driven by the increased popularity of advanced diabetes management options that combine insulin administration with continuous glucose monitoring. This integration increases patient convenience and improves glycemic control.

Continuous Glucose Monitoring Market, By Application

• Type 1 Diabetes
• Type 2 Diabetes
• Gestational Diabetes

Based on Application, the market is segmented into Type 1 Diabetes, Type 2 Diabetes, and Gestational Diabetes. The type 1 diabetes category presently dominates due to its higher prevalence in younger populations and the increased reliance on continuous monitoring for effective management. Patients with Type 1 diabetes require continuous monitoring to maintain glucose control, resulting in high demand for CGM devices in this group. Type 2 diabetes is the fastest growing group, as people become more aware of the necessity of glucose management in preventing complications. With a growing number of persons diagnosed with Type 2 diabetes globally and a shift toward proactive health care, CGM acceptance among these patients is fast increasing.

Continuous Glucose Monitoring Market, By End-User

• Home Healthcare
• Hospitals
• Research Institutes

Based on End-User, the market is segmented into Home Healthcare, Hospitals, and Research Institutes. The hospital segment is currently dominant due to the important necessity for reliable glucose monitoring in inpatient settings, particularly when managing diabetes complications and other related illnesses. Hospitals use CGM systems to offer real-time data, which improves patient care and results. The fastest-growing segment is home healthcare, which is being driven by patients’ rising choice for remote monitoring and self-management. As more people seek simple and accessible healthcare solutions at home, demand for CGM devices designed for personal use is fast increasing, indicating a significant shift toward home-based diabetes management.

Continuous Glucose Monitoring Market, By Geography

• North America
• Europe
• Asia Pacific
• Rest of the World

On the basis of Geography, the Global Continuous Glucose Monitoring Market is classified into North America, Europe, Asia Pacific, and the Rest of the World. North America currently dominates the continuous glucose monitoring (CGM) market, owing to its high diabetes prevalence and well-developed healthcare infrastructure. The Asia-Pacific region is witnessing the fastest growth, owing to rising diabetes rates, rising disposable income, and increased healthcare spending.

Key Players

The “Global Continuous Glucose Monitoring Market” study report will provide valuable insight with an emphasis on the global market. The major players in the market are Dexcom, Inc., Menarini Diagnostics SRL, Sensonics, Medtrum Technologies, Inc., Nemaura Medical, Inc., Ultrahuman Healthcare Pvt Ltd, Medtronic, One Drop, Abbott Laboratories, Inc., and Sinocare. The competitive landscape section also includes key development strategies, market share, and market ranking analysis of the above-mentioned players globally.

Our market analysis also entails a section solely dedicated to such major players wherein our analysts provide an insight into the financial statements of all the major players, along with product benchmarking and SWOT analysis. The competitive landscape section also includes key development strategies, market share, and market ranking analysis of the above-mentioned players globally.

Continuous Glucose Monitoring Market Recent Developments

• In March 2024, The US Food and Drug Administration received marketing permission for the Dexcom Stelo Glucose Biosensor System, an integrated CGM (iCGM). The gadget is intended for those aged 18 and up who do not use insulin, including those with diabetes who manage their disease with oral drugs and those who do not have diabetes but want to learn about the impact of diet and exercise on blood sugar levels.
• In May 2023, Dexcom exhibited G6 CGM at the Japan Diabetes Society’s 66th Annual Meeting. This technology provides diabetic patients with real-time glucose data without the need to prick their fingers.

Report Scope

Research Methodology of Verified Market Research:

To know more about the Research Methodology and other aspects of the research study, kindly get in touch with our Sales Team at Verified Market Research.

Reasons to Purchase this Report

• Qualitative and quantitative analysis of the market based on segmentation involving both economic as well as non-economic factors
• Provision of market value (USD Billion) data for each segment and sub-segment
• Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
• Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
• Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
• Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
• The current as well as the future market outlook of the industry with respect to recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
• Includes in-depth analysis of the market of various perspectives through Porter’s five forces analysis
• Provides insight into the market through Value Chain
• Market dynamics scenario, along with growth opportunities of the market in the years to come
• 6-month post-sales analyst support

Customization of the Report

• In case of any Queries or Customization Requirements please connect with our sales team, who will ensure that your requirements are met.